No Data
No Data
Trump Administration Cancels $12 Billion in Funding to State Health Departments
Pfizer Drops After Report on U.S. Probe Related to Its COVID Vaccine Success
U.S. Reportedly Eyeing Funding Cuts to Gavi, the Global Vaccine Alliance
Deutsche Bank Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $140
Deutsche Bank Sticks to Their Buy Rating for BioNTech SE (BNTX)
Is BioNTech SE (BNTX) a Promising Biotech Stock According to Wall Street Analysts